Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Krystal Biotech Inc chart...

About the Company

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)

$M

Total Revenue

188

Employees

$5B

Market Capitalization

-726.52

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $KRYS News

Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results

20d ago, source:

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.

Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why

4d ago, source: Zacks.com on MSN

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

19d ago, source: Hosted on MSN

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript February 26, 2024 Krystal Biotech, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...

What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock

10d ago, source: Nasdaq

Krystal Biotech, Inc. (KRYS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Krystal Biotech Inc.

4d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Krystal Biotech, Inc. (KRYS) Tops Q4 Earnings and Revenue Estimates

21d ago, source: Nasdaq

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of a loss of $0.52 per share. This compares to loss of $1.25 per share a year ...

Krystal Biotech shares up sharply after it logs revenue from newly approved product

22d ago, source: The Business Journals

Krystal Biotech Inc.'s stock shot up 30% Monday on the Nasdaq stock exchange after the launch of Krystal Biotech's first FDA-approved product in 2023 brought the first stream of revenue for the ...

Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why

4d ago, source: Yahoo Finance

There are several stocks that passed through the screen and Krystal Biotech, Inc. (KRYS) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.

Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript

21d ago, source: Seeking Alpha

Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode. After the ...

Krystal Biotech Inc 4KB

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Q4 2023 Krystal Biotech Inc Earnings Call

21d ago, source: Yahoo Finance

Krish Krishnan; Chairman & CEO; Krystal Biotech, Inc. Suma Krishnan; President of Research & Development; Krystal Biotech, Inc. Kate Romano; Executive VP & CAO ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...